Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).

被引：0
|
作者：
Saltos, Andreas Nicholas
Tanvetyanon, Tawee
Creelan, Ben C.
Shafique, Michael Rahman
Antonia, Scott Joseph
Haura, Eric B.
Zheng, Hong
Barlow, Margaret
Saller, James
Castellano-Fornelli, Anna
Richards, Antoine
Thapa, Ram
Boyle, Theresa A.
Chen, Dung-Tsa
Beg, Amer A.
Gray, Jhanelle Elaine
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat Bioinformat, Tampa, FL USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9567
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results
    Saltos, Andreas Nicholas
    Tanvetyanon, Tawee
    Creelan, Ben C.
    Shafique, Michael Rahman
    Antonia, Scott Joseph
    Haura, Eric B.
    Zheng, Hong
    Yu, Xiaoqing
    Saller, James Joseph
    Viracacha, Sebastian
    Thapa, Ram
    Boyle, Theresa A.
    Chen, Dung-Tsa
    Beg, Amer A.
    Gray, Jhanelle Elaine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).
    Saltos, Andreas Nicholas
    Tanvetyanon, Tawee
    Williams, Charles C.
    Haura, Eric B.
    Creelan, Ben C.
    Antonia, Scott Joseph
    Tchekmedyian, Nishan
    Goas, Kristen
    Mamplata, Trevor
    Thapa, Ram
    Chen, Dung-Tsa
    Beg, Amer A.
    Gray, Jhanelle Elaine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Updated results.
    Saltos, Andreas Nicholas
    Tanvetyanon, Tawee
    Haura, Eric B.
    Creelan, Ben C.
    Antonia, Scott Joseph
    Shafique, Michael Rahman
    Zheng, Hong
    Dai, Wenjie
    Chen, Zhihua
    Saller, James Joseph
    Tchekmedyian, Nishan
    Goas, Kristen
    Thapa, Ram
    Boyle, Theresa A.
    Chen, Dung-Tsa
    Beg, Amer A.
    Gray, Jhanelle Elaine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] A Phase I/II Trial of IO102 and Pembrolizumab With/Without Chemotherapy as First-line Treatment of Metastatic NSCLC
    Provencio, M.
    Spicer, J.
    Garrido, P.
    Trigo Perez, J. M.
    Viteri, S.
    Bosch-Barrera, J.
    Insa, A.
    Felip, E.
    De Castro Carpeno, J.
    Coart, E.
    Schmidt, E.
    Christiansen, A.
    Andersen, M. Hald
    Zocca, M.
    Ehrnrooth, E.
    Paz-Aras, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S643 - S643
  • [5] Pembrolizumab (Keytruda) for First-Line Treatment of Metastatic NSCLC
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1513): : 4 - 5
  • [6] Phase 3, Randomized, Double-Blind Trial of First-Line Pembrolizumab With or Without Lenvatinib in Metastatic NSCLC: LEAP-007
    Mekhail, T.
    Kim, S.
    Kubota, K.
    Del Riego, M. Gonzalez
    Wu, L.
    Samkari, A.
    Fouad, T. M.
    Yang, J. Chih-Hsin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S405 - S405
  • [7] Sarcopenia is not a useful prognostic biomarker in metastatic NSCLC patients treated with first-line pembrolizumab
    Thomson, Findlay
    Stratton, Cory
    Stares, Mark
    Ding Tze-en
    Phillips, Iain
    [J]. LUNG CANCER, 2021, 156 : S42 - S42
  • [8] Phase I trial of Pemetrexed, Carboplatin and Sorafenib as first-line treatment in patients with metastatic NSCLC
    Brandts, C.
    Borchard, B.
    Waller, C. F.
    Martens, U. M.
    Kerhoff, A.
    Mohr, M.
    Young, C.
    Gerss, J.
    Serve, H.
    Berdel, W. E.
    Wiewrodt, R.
    [J]. ONKOLOGIE, 2010, 33 : 170 - 171
  • [9] A Phase II Trial of Pictilisib with Chemotherapy in First-Line Squamous NSCLC
    Spigel, David
    Luft, Alexander
    Vynnychenko, Ihor
    Fadeeva, Natalia
    Mark, Zsuzsanna
    Ponce, Santiago
    Matrosova, Marina
    Goldschmidt, Jerome
    Szima, Barna
    Saleh, Mansoor
    Lackner, Mark
    Gendreau, Steve
    Bassett, Katia
    Spoerke, Jill
    Koeppen, Hartmut
    Gilbert, Houston
    Jin, Huan
    Shankar, Geetha
    Lin, Wei
    Denis, Fabrice
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S375 - S375
  • [10] Obesity is Associated With Greater Overall Survival in Patients With Metastatic NSCLC Receiving First-Line Pembrolizumab
    Thomson, F.
    Stratton, C.
    Phillips, I.
    Mackean, M.
    Barrie, C.
    Campbell, S.
    Tufail, A.
    Maclennan, K.
    Evans, T.
    Stares, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S965 - S966
12345